Literature DB >> 21386784

From imaging to dosimetry and biological effects.

M Konijnenberg1.   

Abstract

The essential steps are explained in calculating a radiation dose for radionuclide therapy from imaging data. As the dose alone is a meaningless value, its consequences in tumour cell kill efficiency and normal tissue damage are explained. The influence of dose rate and inhomogeneous dose distributions are discussed.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21386784

Source DB:  PubMed          Journal:  Q J Nucl Med Mol Imaging        ISSN： 1824-4785            Impact factor:   2.346


  4 in total

Review 1.  Clinical radioimmunotherapy--the role of radiobiology.

Authors:  Jean-Pierre Pouget; Isabelle Navarro-Teulon; Manuel Bardiès; Nicolas Chouin; Guillaume Cartron; André Pèlegrin; David Azria
Journal:  Nat Rev Clin Oncol       Date:  2011-11-08       Impact factor: 66.675

2.  A population-based method to determine the time-integrated activity in molecular radiotherapy.

Authors:  Deni Hardiansyah; Ade Riana; Peter Kletting; Nouran R R Zaid; Matthias Eiber; Supriyanto A Pawiro; Ambros J Beer; Gerhard Glatting
Journal:  EJNMMI Phys       Date:  2021-12-14

3.  Kidney dosimetry in ¹⁷⁷Lu and ⁹⁰Y peptide receptor radionuclide therapy: influence of image timing, time-activity integration method, and risk factors.

Authors:  F Guerriero; M E Ferrari; F Botta; F Fioroni; E Grassi; A Versari; A Sarnelli; M Pacilio; E Amato; L Strigari; L Bodei; G Paganelli; M Iori; G Pedroli; M Cremonesi
Journal:  Biomed Res Int       Date:  2013-06-20       Impact factor: 3.411

4.  Investigating the Effect of Ligand Amount and Injected Therapeutic Activity: A Simulation Study for 177Lu-Labeled PSMA-Targeting Peptides.

Authors:  Peter Kletting; Christiane Schuchardt; Harshad R Kulkarni; Mostafa Shahinfar; Aviral Singh; Gerhard Glatting; Richard P Baum; Ambros J Beer
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.